Globus Medical, Inc.
GMED
$91.70
-$2.10-2.24%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.18% | -41.35% | 168.81% | 184.71% | -48.87% |
| Total Depreciation and Amortization | -3.35% | 0.75% | 6.86% | -1.36% | -0.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.02% | 141.56% | -632.72% | -70.85% | 79.68% |
| Change in Net Operating Assets | -1,335.44% | 103.07% | -689.81% | -64.79% | -21.78% |
| Cash from Operations | -0.44% | 220.68% | -56.08% | -15.71% | 3.28% |
| Capital Expenditure | -28.98% | 23.08% | -28.97% | -110.99% | 59.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -63.03% | -- | -100.00% | 292.49% | -421.25% |
| Cash from Investing | -46.95% | 74.64% | -327.66% | 226.18% | -595.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | 466.46% | 135.87% | -58.15% | -83.80% | 194.76% |
| Repurchase of Common Stock | -13.75% | -54.89% | 86.69% | -20,536.40% | -11.19% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -28.32% | 15.05% | -2.16% | 54.85% | -179.56% |
| Cash from Financing | 141.24% | -28.49% | 96.08% | -1,163.73% | 205.02% |
| Foreign Exchange rate Adjustments | 687.89% | -96.43% | 305.76% | 182.73% | -205.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.48% | 161.39% | 28.27% | -299.89% | -23.86% |